P R O F E S S I O N A L P R A C T I C E M AT E R I A L S
NR546 Midterm Exam
Questions & Answers,
Updated 2026/2027 Edition
Verified Answers Exam Ready 289 QUESTIONS
DOCUMENT OVERVIEW
This document contains 289 questions with provided correct answers, covering
psychiatric-mental health nursing. It is an invaluable resource for students to study and
review essential concepts, directly aligning with preparation for certification exams.
TOPICS
• Benzodiazepines and Sedatives • Adverse Effects and Monitoring
• Genetics and Epigenetics in Mental • Neuroanatomy and Brain Function
Health
• Specific Symptom and Condition • Legal, Ethical, and Societal
Management Considerations
• Psychopharmacology Fundamentals • Neurotransmission and
Neurotransmitters
• Antidepressant Medications • Anxiety Disorders and Management
• Antipsychotic Medications: Overview • Antipsychotic Medications: Specific
Agents
Page 1
, E XA M Q U EST I O N S
Q1 QUESTION 1 OF 289
What should the PMHNP consider when prescribing chemical restraints?
ANSWER
-allergy status
-prior med hx for adverse drug reactions r/t the meds ordered in the chemical restraint
-state regulations regarding chemical restrains must be reviewed
Q2 QUESTION 2 OF 289
Are the PMHNP and other staff liable if the client has an allergic reaction or adverse side
effects to the drugs used for chemical restraint?
ANSWER
No.
The client has been court-ordered to take the prescribed medications and the standing order
for chemical restraints is approved. The PMHNP and other staff are not liable if the patient has
an allergic reaction or adverse side effects.
Q3 QUESTION 3 OF 289
effect on neurotransmitters and side effects: Benzodiazepines
ANSWER
Increases the receptor affinity for GABA, which can cause dependence and confusion
Q4 QUESTION 4 OF 289
Commonly prescribed antipsychotic medications for treatment of positive schizophrenic
symptoms
Page 2
, ANSWER
lowest to highest potency - FGAs
-chlorpromazine (low)
-mesoridazine (low)
-thioridazine (low)
-thiothixene (med)
-fluphenazine (med)
-haloperidol (high)
Q5 QUESTION 5 OF 289
Sedative-hypnotic agents
ANSWER
benzodiazepine & barbiturates, clinical indications for use:
-sedation & anxiolysis
-treatment of insomnia
-general anesthesia
-seizures
-alcohol withdrawal states
-as adjunctive management with neuromuscular blockage/muscle relaxation
-to induce or maintain sleep
Q6 QUESTION 6 OF 289
sedative-hypnotic medications: use
ANSWER
-1 in 8 adults
-Higher incidence in older adults
-Often co-prescribed with opioids
Q7 QUESTION 7 OF 289
sedative-hypnotic medications: misuse
Page 3
, ANSWER
-Taken outside of prescriptive guidelines
-Taken without prescription
-polysubstance Abuse
-Are common as second drugs of abuse, often taken with opioids and/or alcohol
-Increased respiratory and CNS depression
-Increased risk of emergency department visits
Q8 QUESTION 8 OF 289
sedative-hypnotic medications: Withdrawal
ANSWER
-May be severe
-Signs and symptoms include psychosis, hallucinations, delirium, seizures
-Mild signs and symptoms: irritability, tremor, anxiety, palpitations, insomnia, nausea, vomiting,
diaphoresis, headache
Q9 QUESTION 9 OF 289
Benzodiazepine intoxication
ANSWER
Can resemble alcohol intoxication: unsteady gait, cognitive impairment, discoordination,
slurred speech
-Overdose may lead to respiratory depression and stupor/coma
Q10 QUESTION 10 OF 289
Benzodiazepines (BZOs)
Page 4
NR546 Midterm Exam
Questions & Answers,
Updated 2026/2027 Edition
Verified Answers Exam Ready 289 QUESTIONS
DOCUMENT OVERVIEW
This document contains 289 questions with provided correct answers, covering
psychiatric-mental health nursing. It is an invaluable resource for students to study and
review essential concepts, directly aligning with preparation for certification exams.
TOPICS
• Benzodiazepines and Sedatives • Adverse Effects and Monitoring
• Genetics and Epigenetics in Mental • Neuroanatomy and Brain Function
Health
• Specific Symptom and Condition • Legal, Ethical, and Societal
Management Considerations
• Psychopharmacology Fundamentals • Neurotransmission and
Neurotransmitters
• Antidepressant Medications • Anxiety Disorders and Management
• Antipsychotic Medications: Overview • Antipsychotic Medications: Specific
Agents
Page 1
, E XA M Q U EST I O N S
Q1 QUESTION 1 OF 289
What should the PMHNP consider when prescribing chemical restraints?
ANSWER
-allergy status
-prior med hx for adverse drug reactions r/t the meds ordered in the chemical restraint
-state regulations regarding chemical restrains must be reviewed
Q2 QUESTION 2 OF 289
Are the PMHNP and other staff liable if the client has an allergic reaction or adverse side
effects to the drugs used for chemical restraint?
ANSWER
No.
The client has been court-ordered to take the prescribed medications and the standing order
for chemical restraints is approved. The PMHNP and other staff are not liable if the patient has
an allergic reaction or adverse side effects.
Q3 QUESTION 3 OF 289
effect on neurotransmitters and side effects: Benzodiazepines
ANSWER
Increases the receptor affinity for GABA, which can cause dependence and confusion
Q4 QUESTION 4 OF 289
Commonly prescribed antipsychotic medications for treatment of positive schizophrenic
symptoms
Page 2
, ANSWER
lowest to highest potency - FGAs
-chlorpromazine (low)
-mesoridazine (low)
-thioridazine (low)
-thiothixene (med)
-fluphenazine (med)
-haloperidol (high)
Q5 QUESTION 5 OF 289
Sedative-hypnotic agents
ANSWER
benzodiazepine & barbiturates, clinical indications for use:
-sedation & anxiolysis
-treatment of insomnia
-general anesthesia
-seizures
-alcohol withdrawal states
-as adjunctive management with neuromuscular blockage/muscle relaxation
-to induce or maintain sleep
Q6 QUESTION 6 OF 289
sedative-hypnotic medications: use
ANSWER
-1 in 8 adults
-Higher incidence in older adults
-Often co-prescribed with opioids
Q7 QUESTION 7 OF 289
sedative-hypnotic medications: misuse
Page 3
, ANSWER
-Taken outside of prescriptive guidelines
-Taken without prescription
-polysubstance Abuse
-Are common as second drugs of abuse, often taken with opioids and/or alcohol
-Increased respiratory and CNS depression
-Increased risk of emergency department visits
Q8 QUESTION 8 OF 289
sedative-hypnotic medications: Withdrawal
ANSWER
-May be severe
-Signs and symptoms include psychosis, hallucinations, delirium, seizures
-Mild signs and symptoms: irritability, tremor, anxiety, palpitations, insomnia, nausea, vomiting,
diaphoresis, headache
Q9 QUESTION 9 OF 289
Benzodiazepine intoxication
ANSWER
Can resemble alcohol intoxication: unsteady gait, cognitive impairment, discoordination,
slurred speech
-Overdose may lead to respiratory depression and stupor/coma
Q10 QUESTION 10 OF 289
Benzodiazepines (BZOs)
Page 4
